24 completed, 3 recruiting, 2 active not recruiting, 1 not yet recruiting. 33 Phase 2, 4 Phase 1, 1 Phase 3.
Follow Opportunistic Infections: new trials by email Literature Review of Opportunistic Infections trials Research Report on Opportunistic Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS Sintilimab - HIV, AIDS | Phase 1 / Phase 2 | Not yet recruiting | Shanghai Public Health Clinical Center | 50 | 2026-05-01 | 2026-05-12 |
| A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia Recombinant human interleukin (IL) 7-hyFc - Idiopathic CD4 Lymphopenia | Phase 1 / Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 60 | 2024-11-06 | 2026-10-19 |
| Early Versus Conventional Cessation of Hydrocortisone in Septic Shock normal saline solution, Hydrocortisone and normal saline solution - Septic Shock, Adverse Event | Phase 2 | Unknown | Mahidol University | 160 | 2023-07-05 | 2024-04-05 |
| Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity Busulfan test dose, Fludarabine, Busulfan - Lymphoproliferative Disorders, Autoimmune Lymphoproliferative | Phase 2 | Recruiting | National Cancer Institute (NCI) | 66 | 2020-09-22 | 2026-11-12 |
| Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma ATL-RIC, mRIC, allo HCT - Peripheral T-cell Lymphomas, Lymphoproliferative Disorders | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 118 | 2019-04-18 | 2026-11-09 |
| Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation e-ATG, Immunosuppression Only Conditioning, Reduced Intensity Conditioning - Lymphoproliferative Disorders, Autoimmune Lymphoproliferative | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 71 | 2018-09-04 | 2026-03-17 |
| CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT CD45RA-depleted peripheral blood mononuclear cells - Leukemia, Lymphoma | Phase 2 / Phase 3 | Completed | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 150 | 2016-10-01 | 2023-03-16 |
| Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies Immunosuppression Only Conditioning -Closed with amendment L, Reduced Intensity Conditioning, Myeloablative Conditioning-Closed with amendment L - Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency | Phase 2 | Recruiting | National Cancer Institute (NCI) | 354 | 2015-11-19 | 2026-11-05 |
| Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation CD45RA-depleted peripheral blood mononuclear cells - Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute | Phase 1 / Phase 2 | Completed | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 30 | 2014-08-01 | 2016-04-22 |
| A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3 Nelfinavir mesylate - Sarcoma, Kaposi, HIV Infections | Phase 2 | Completed | Agouron Pharmaceuticals | 20 | 2005-06-24 | |
| Dexamethasone in Cryptococcal Meningitis Flucytosine, Fluconazole, Amphotericin B - Meningitis, Cryptococcal, HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 36 | 2021-10-28 | |
| A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC) Nelfinavir mesylate - Mycobacterium Avium-Intracellulare Infection, HIV Infections | Phase 2 | Completed | Agouron Pharmaceuticals | 2005-06-24 | ||
| A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Atovaquone, Sulfamethoxazole-Trimethoprim - Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 300 | 2011-03-01 | |
| A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir Foscarnet sodium - Cytomegalovirus Retinitis, HIV Infections | Phase 2 | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-11-04 | ||
| A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Sitamaquine - Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 45 | 2021-10-28 | |
| A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure Foscarnet sodium - Cytomegalovirus Retinitis, HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 156 | 2021-11-03 | |
| Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole L-743,872 - Candidiasis, Oral, HIV Infections | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 70 | 2005-06-24 | |
| A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3 Zidovudine, Acyclovir - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 400 | 2021-11-04 | |
| A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT) Sevirumab - Cytomegalovirus Retinitis, HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 300 | 2012-10-25 | |
| A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium Nitazoxanide - Cryptosporidiosis, HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 60 | 2021-11-01 |
Showing 20 of 33. Sign in to see all of them.
AIDS-Related Opportunistic Infections (24) · HIV Infections (24) · Acquired Immunodeficiency Syndrome (13) · Cytomegalovirus Retinitis (6) · Autoimmune Diseases (4) · Cytomegalovirus Infections (4) · Immune System Diseases (4) · Lymphoproliferative Disorders (4) · Multiple Acyl Coenzyme A Dehydrogenase Deficiency (4) · Common Variable Immunodeficiency (3) · Mycobacterium avium-intracellulare Infection (3) · Retinitis (3) · T cell immunodeficiency primary (3) · Candidiasis, Oral (2)
Infections (33) · Immunologic Deficiency Syndromes (29) · Immune System Diseases (28) · Blood-Borne Infections (25) · Communicable Diseases (25) · Genital Diseases (25) · Lentivirus Infections (25) · RNA Virus Infections (25) · Retroviridae Infections (25) · Sexually Transmitted Diseases (25) · Sexually Transmitted Diseases, Viral (25) · Urogenital Diseases (25) · Virus Diseases (25) · Slow Virus Diseases (14)
Foscarnet (3) · Nelfinavir (3) · Busulfan (2) · Clarithromycin (2) · Cyclophosphamide (2) · Fluconazole (2) · Ganciclovir (2) · Mycophenolic Acid (2) · Tacrolimus (2) · Zidovudine (2) · nitazoxanide (2) · sevirumab (2) · 8-aminoquinoline (1) · Absorptiometry, Photon (1) · Acyclovir (1)
National Institute of Allergy and Infectious Diseases (NIAID) (16) · National Cancer Institute (NCI) (4) · Agouron Pharmaceuticals (3) · Anderson Clinical Research (2) · Federal Research Institute of Pediatric Hematology, Oncology and Immunology (2) · Ionis Pharmaceuticals, Inc. (1) · Mahidol University (1) · Merck Sharp & Dohme LLC (1) · Schering-Plough (1) · Shanghai Public Health Clinical Center (1) · SmithKline Beecham (1)
United States (26) · Thailand (3) · Belgium (2) · Canada (2) · France (2) · Germany (2) · Puerto Rico (2) · Russia (2) · South Africa (2) · Argentina (1) · Chile (1) · China (1) · Dominican Republic (1) · Ethiopia (1) · Guatemala (1)
Dimana Dimitrova, M.D. (3) · MA Jacobson (2) · Andrea Lisco, M.D. (1) · Black J (1) · Borucki M (1) · C Crumpacker (1) · CS Crumpacker (1) · Chaisson R (1) · Collier AC (1) · Corey L (1) · D Richman (1) · Dohn M (1) · Fichtenbaum C (1) · Frame P (1) · Gnann J (1)